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Towards Technological Rules for Designing Innovation
Networks: a Dynamic Capabilities View
Abstract
Purpose - Interorganizational innovation networks are providing opportunities to
exploit superior resources that reside beyond the boundary of the firm. The shifting
locus of innovation and value creation away from the ‘sole firm as innovator’ poses
important questions about the nature of resources that exist in the spaces between
firms, and the capabilities needed to leverage them for competitive advantage. The
purpose of this research is to produce design-oriented knowledge, for configuring
interorganizational networks as a means of accessing such resources for innovation.
Methodology / Approach – This exploratory investigation conflates emerging
constructs and themes analytically induced from a systematic survey of 142 scholarly
and practitioner articles and 45 expert interviews with senior professionals operating
in the biopharmaceuticals industry. Findings and Practical Implications – The
findings identify 7 theoretically and empirically grounded technological rules
associated with effective interorganizational networking for innovation. They
embody evidence ex post of networking theory and practice. Based on van Aken’s
seminal work, they comprise vital design-oriented knowledge to provide a solution
architecture of viable action options for managers, a priori, to purposefully design
innovation networks. Collectively these rules represent a tentative taxonomy, a means
of classifying design principles, to assist managers in navigating their decision
making processes. Originality/value of paper - This study demonstrates the need
for explicit design-oriented knowledge for configuring interorganizational networks.
Finally, the implications of the findings for strategic management theory are discussed
from a Dynamic Capabilities view. The significance of a dynamic capability which
addresses the renewal of network-specific resources is highlighted.
Keywords: Interorganizational Networks, Innovation, Resource-based View,
Dynamic Capabilities View, Biopharmaceuticals
Paper Category: Research Paper
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Introduction
Competitive global businesses environments remain congruent with Eisenhart’s
(1989) notion of high velocity and D’Aveni’s (1994) concept of hyper competition, in
which technological innovations are frequent and potentially path breaking. Under
such dynamic conditions, the effective renewal of products/services and how they are
delivered are critical capabilities for many high tech industries (Bartlett and Ghoshal,
2002; Zahra and Nielsen, 2002; Lovas and Ghoshal, 2000; Markides and Geroski,
2003 and Bessant, 2003). This is a major concern for the traditional pharmaceuticals
and emerging biopharmaceuticals sector where advancements in the field of
genomics, proteomics, bioinformatics and biotechnology are increasingly of a
discontinuous nature. Thus making the development of innovative medicines a risky
and expensive process that demands organizational capabilities conducive to radical
innovation.
Research is beginning to illustrate how relatively novel organizational forms such as
‘networks’ are being deployed to access new technologies and their associated know-
how to improve innovation capacity (George et al, 2002, Hagedoorn and Duysters,
2002). Such opportunities to exploit superior external knowledge resources often
come with the promise of new products for new markets. The use of innovation
networks has become a distinctive feature of the rapidly growing biopharmaceuticals
sector. Liesband et al (1996) in their study of New Biotechnology Firms (NBF)
consider three organizational options for sourcing scientific knowledge: internal
sourcing via internal hierarchies, external sourcing through markets exchanges and
external sourcing through organizational networks. Granovetter (1985) and Powell
(1998) provide a critique of the traditional hierarchies and markets viewpoint in
suggesting that, its use does not acknowledge the importance of the social dimension
as a means of governing business exchange, which is often predicated on trust. Tidd
(1995) points out that whilst the network concept appears relatively novel and able to
overcome the ‘market vs. hierarchies’ debate, as a so-called ‘third way’, it is echoed
in earlier research by Rumelt in the 1970s and Rothwell’s (1994) Fifth Generation
model of innovation. More recently, Chesbrough’s notion of Open Innovation and
Bessant’s (2004) idea of High Involvement Innovation also replay similar generic
arguments regarding the use of networks and confirm their potential to create new
value. Coombs & Metcalfe’s (2002) argue that whilst the pharmaceutical sector has
traditionally enjoyed considerable organic growth as a result of their patents,
intellectual property, technologies, marketing and production capabilities, today’s
competitive environment is demanding fundamental changes to the way they do
business. In particular, Coombs & Metcalfe are intrigued by way in which these firms
have avoided a reliance on external expertise in the face of new biotechnological
advancements, and how in recent years this climate has forced them to combine,
reconfigure, integrate and coordinate resources within what they have termed a
‘distributed innovation system’.
A Dynamic Capabilities View of Biopharmaceuticals Product Development
Biopharmaceutical product development is reliant on complementary resources
bestowed by different organizations in a wider network, which is often globally
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dispersed. Such networks may include universities, clinical research organizations
(CRO), pharmaceuticals companies; small genomics research laboratories,
independent financiers, proprietary technology providers and other new biotechnology
firms (NBFs). The pooling effect of resources as an organizational level activity has
been portrayed in other high tech industries (Hankasson, 1990) as a ‘network
approach’ to innovation (Bower, 1993). Unlike other approaches (e.g. resource
dependency, transaction cost and agency) it seeks to understand how the focal firm
and its peripheries change the multi-player (or network) context through their
interactions. Such new industry settings are shifting the locus of knowledge, learning
and value creation beyond the boundary of the single firm and into the network, with
important implications for its future management and organization.
The Resource Based View (RBV) of the firm is a useful theoretical framework for
understanding how such dynamics lead to competitive advantage (Barney, 1991;
Nelson, 1991; Penrose, 1959; Prahalad and Hamel, 1990; Teece et al, 1997). As a
progressively dominant theoretical view in the field of strategic management, it
concerns itself with resources as being critical to a firm’s competitive advantage and
long-term survival. Whilst importance is attached to all physical and organizational
resources, special reference is made to knowledge and competencies based resources.
In connecting the RBV to dynamic market environments more closely, Teece et al
(1997) discuss the notion of ‘dynamic capabilities’ through which managers
‘integrate, build and reconfigure internal and external competencies to address
changing environments’ (Teece et al 1997). As a body of knowledge that has
progressed rapidly over the last few decades it explores the nature of such capabilities,
and their distinguishing characteristics. A main thrust of this literature argues that
dynamic capabilities are essentially organizational routines deployed to alter a
resource base by ‘acquiring, creating, shedding, integrating, and recombining existing
resources to generate new value creating strategies’ (Pisano, 1996). Whilst the
functionality of dynamics capabilities is generic and applicable across business
contexts, their value lies in the resource configurations they create and not in the
capabilities themselves (Eisenhardt and Martin, 2000).
Like Preim and Butler (2001) in their recent portrayal of the limitations of Barney’s
RBV, Eisenhardt and Martin (2000) suggest that the RBV misjudges the locus of
long-term competitive advantage in dynamic markets. In considering this suggestion
in the context of biopharmaceutical new product development (biopharma NPD), the
prevailing industry dynamics are shifting the locus of knowledge and value creation
within the supply and demand chains. Therefore it seems plausible to propose that
innovation, and hence competitive advantage, cannot be simply manipulated from
within the boundary of a single firm, as presumed by a traditional RBV perspective,
but rather from within a network of heterogeneous firms. This poses questions
concerning the nature of resources that exist in the space between firms and how they
are leveraged. Such inquiries are relevant to operationalizing interorganizational
innovation networks effectively, a topic which to date has witnessed a significant lack
of management research to produce design-oriented knowledge. This research
deploys van Aken’s seminal ideas of generating design-oriented knowledge through
the development of what he calls ‘grounded and field-tested technological rules’ (van
Aken, 2005).
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This paper presents 7 empirically and theoretically grounded technological rules
associated with effective interorganizational networking for innovation. These rules
embody evidence ex post of networking theory and practice. In doing so, the rules
compose vital design-oriented knowledge which provides solution architecture of
viable action options for managers a priori, to purposefully design innovation
networks. Collectively these rules represent a tentative taxonomy, a means of
classifying design principles, to assist managers in navigating their decision making
processes and devising appropriate network development strategies. It acts as a useful
framework for evaluating current managerial practice and considering the range of
possibilities available to guide future action. In doing so, it constitutes valuable
transferable knowledge to support improvements in innovation capacity and
performance. The investigation conflates emerging constructs and themes
analytically induced from a systematic survey of 142 scholarly articles and 45 expert
interviews with senior professionals in the burgeoning global biopharmaceuticals
sector. The resultant synthesis is recommended for further field-testing, as an
important antecedent to management action to better inform the broader practice of
managing innovation in an increasingly multi-player (or network) context. The
managerial implications of each rule associated with designing innovation networks
are considered. Finally, the strategic management propositions of the research have
been discussed from a Dynamic Capabilities view, and in particular its failure to
adequately address capabilities associated with the renewal of network-specific
resources.
Methods
This research adopts van Aken’s (2005) eloquent diagnosis of the discipline of
management as a ‘design science’ (similar to medicine and engineering) to be distinct
from the ‘explanatory’ sciences (similar to physics, chemistry and biology). He
suggests the science of management is primarily concerned with the need to produce
design-oriented knowledge via ‘grounded and field tested technological rules’ based
on Bunge’s notion of ‘technological rules’ (1967). van Aken (2005) advocates the
view that field testing these rules in the real world enables descriptive knowledge to
be applied, and transformed into actionable design knowledge. This design
knowledge provides a solution architecture composing viable action options for
managers, and so an important antecedent to management practice.
As a leading researcher in the field of innovation management van Aken is a prolific
supporter of research conducted within the framework of a Mode 2 knowledge
production system, and ‘in the context of application’ (Gibbons et al, 1994; Huff,
2000; Nowotny et al, 2001). Mode 2 research is multidisciplinary and seeks to solve
complex and relevant problems in the field, as distinct from Mode 1 research which is
often disciplinary and drives further research enquiry, as often evident in the natural
sciences.
This study upholds innovation management as a branch of management research and
corroborates van Aken views that richness can be gained through combining both
mode 1 and mode 2 strategies. In doing so, quantitative and qualitative data from two
complementary research phases deploying Systematic Review (SR) and empirical
semi-structured interviews are conflated. The resultant synthesis of 7 empirically and
Towards Technological Rules for Designing Innovation Networks: a Dynamic Capabilities View
6
theoretically grounded technological rules is recommended for further field-testing.
The following sections describe each of the research phases.
Sample and Procedure
Phase 1: Systematic Review
An extensive Systematic Review (SR) of the extant literature sought to identify key
constructs influencing effective interorganizational networking practice. The SR
adopts an evidenced based approach to assimilating secondary data using peer review
and formalized criteria, based on its principal use in the medical field. It has a defined
protocol designed to provide a transparency and auditability based on Tranfield et al
(2003) as follows:
 An initial investigation of the ABI Proquest database was undertaken through
search strings using the keywords in table 1. This as conducted within a select list
of international scholarly and practitioner journals in the management science
field. The search resulted in a total of more than 1500 articles, from which 142
articles were selected for further review based on specific inclusion/exclusion
criteria set in accordance with the research aims and objectives. A sector focus
was imposed to include management research in the pharmaceuticals,
biotechnology and biopharmaceuticals domains.
 A database of the included 142 articles formed an ‘A’ list for subsequent
quantitative and qualitative analysis.
 The ‘A’ list was initially subject to demographic analysis to gauge deeper
understanding of the nature and form of the dataset.
 Summaries of the ‘A’ list articles were transferred onto data recording sheets for
subsequent theme based content analysis, open coding and generation of higher
order themes.
 A synthesis of this extant literature led to emergence of major constructs which
were subsequently conflated with phase 2 of the study.
Table 1: Systematic Review: Keywords
‘Keywords’ for search string formation
social capital
innovation network
innovation AND network
network* AND (pharma* OR biotech*)
Strategic alliance* AND (pharma* OR biotech*)
Total number of articles reviewed 142
Phase 2: Empirical study
The aim of this exploratory investigation was to gain novel insights into the growing
practice of interorganizational innovation. Therefore 45 semi-structured interviews
with senior professionals in the biopharmaceuticals field were conducted, initially to
examine major shifts in management practice regarding:
 biopharma NPD over the past 20 years
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 interorganizational innovation as an explicit NPD strategy
 enablers and barriers to implementing effective interorganizational innovation
 how drug development specialists acquire new sources of knowledge
 current and future challenges facing drug development firms
 support for the future of biopharma NPD
This exploratory approach relies heavily on analytical induction which does not require
probability based sampling techniques, because an important aim of the study is to generate
further avenues of research inquiry (Yin, 2003). The research sample, shown in table 2, was
selected using a modified ‘snowballing’ technique (Miles & Huberman, 1994), whereby the
initial informants were identified by the research partners, for their high profile
responsibilities across organizational and disciplinary boundaries in a biopharma NPD
context.
Table 2 The Sample of Respondents
Type of firm No. of
firms
No. of
interviews
Exemplar informants
Big
Pharmaceuticals
4 12 Vice President Biology, Head of Bioinformatics, R&D
Manager, Manager, Capacity & Resource Planning
Biotechnology 3 10 Head of Drug Discovery , Vice President, Strategic
Alliances, Vice President Sales
Life Sciences
Consultancy
4 10 Associate Partner, Director Pharmaceuticals R&D,
Principal Managing Consultant, Group Head
Pharmaceuticals R&D Europe
Biotechnology
Professional
Association
2 4 CEO BioIndustry Association (UK), Director of
Bioprocess UK, Business Development Director, CEO
Regional Biotechnology Initiative
Academic
Institutions
6 9 Professor, Senior Lecturer, Senior Researchers
Total 19 45
The interviews ranged from between 45 minutes to 3 hours in duration, and where possible
tape recorded for subsequent transcription. In the small number of cases where consent for
tape recording was not forthcoming, detailed notes were made during and after the interview.
The transcriptions and notes generated a substantial dataset for qualitative analysis. A process
of analytical induction using Theme Based Content Analysis (TBCA) revealed 6 second order
themes induced from 34 first order open codes. Generic themes materialized through the
expansion and contraction of key constructs, based on coding instances within the
personalized accounts of interviewees, which further refined the clustering process. In
addition to this, corporate documentation and other archival records were also included for
analysis where available.
Findings
Phase 1: Systematic Review
The Systematic Review (SR) protocol identified 10 key constructs influencing
effective interorganizational networking practice for innovation, from the extant
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literature. Table 3 incorporates these constructs as a theoretical framework, and the
outcome of a process of qualitative induction. Each of these constructs is briefly
discussed in the following sections and subsequently conflated with the findings of
the empirical study.
The full ‘A’ list of 142 articles shows a relatively even split of European, UK and US
published items. Furthermore 102 of these items were empirically based, 15
presented explicit design guidance in relation to innovation networks and whilst 77
upheld a strong knowledge based view, only 10 discussed the research findings from a
Dynamic Capabilities view.
Table 3: Theoretical framework
Key constructs influencing effective interorganizational networking
practice for innovation
Number of
citations
Percentage
%
Dynamic view 14 4
Process and structure 63 16
Unintended consequences 20 5
Heterogeneity 48 12
Openness and security 44 11
Connectivity 52 13
Learning and knowledge transfer 43 11
Relationship management 49 13
Continuous and discontinuous renewal 30 8
Complexity and embeddedness 26 7
Dynamic view
A significant proportion of the literature discusses the use of networks and learning
from a dynamic view that illustrates the changing nature of organizational ties over
time. Networks are considered from an evolutionary life cycle perspective with
different phases of development which happen over a period of time (Pyka & Saviotti,
2001; Kreiner & Schultz, 1993). For example, there is usually an initiation phase,
growth phase, stability phase and then a maturity phase, whereby the network might
spur new connections or perhaps the existing connections might become dormant,
only to be rejuvenated with a change in context at a later point in time. The
dimension of time acknowledges that whilst a network may have a life span,
individual connections are not necessarily product or network development phase-
specific and will eventually develop their own history and path dependencies
(Orsenigo et al, 2001 and Powell et al, 1996). Learning in networks is enhanced due
to firm’s increased opportunities to access new sources of knowledge through a
variety of external linkages. Therefore networked firms are conducive to developing
their capacity to absorb knowledge from external sources (i.e. absorptive capacity)
and organizational routines for doing so (i.e. collaborative capacity).
Structure and process
The outcomes of network organizational arrangements can be enhanced, if both the
wider network and specific network connections are actively managed and structured
from initial inception to end-of-life (Pittaway et al, 2004). Whilst an active
management approach engenders formality, it is prudent to overtly facilitate the
conditions conducive to releasing the potential benefits often associated with the
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informal nature of networks. For example, Bessant et al (2001) in their study of
supply, innovation and learning networks articulate a framework of 8 generic
processes for actively managing network dynamics based on the work by Gandori and
Soda (1995). These include network creation, decision-making, conflict resolution,
information processing, knowledge capture, integration, risk/benefit sharing as
explicit processes to be managed.
Unintended consequences
Networks have emergent properties and creating conditions to foster serendipity can
be advantageous in achieving both intended and non-intended outcomes. A good start
might be to positively encourage social networking through planned attendances at
various business conferences, industry forums etc., with a view of using this platform
to promote formal partnering (Kreiner & Schultz, 1993). It is important to realize that
the foundation of effective networks will also emerge informally over time, but then a
repertoire of processes need to be undertaken which follows an incremental and
sequential transition from loose conversations and discussions to defined contractual
obligations (Powell, 1998; Oliver & Liebeskind, 1998). Managers in their role as
‘network architects’ must recognize that there are opportunities to capitalize upon the
emergent properties of network dynamics. This may require significant investments
in time and other resources to build professional trust, respect and loyalty amongst
various networked firms, with a view to this being a sound basis for future exchange.
Heterogeneity
Organizational networks in the biopharmaceuticals sector are becoming diverse as
firms recognize that future sources of innovation lie beyond the boundary of the firm.
Network building strategies are being shaped by the increasing specialisation and
fragmentation of scientific and technological knowledge in this sector’s quest for
complementarities and synergies between the offerings of different firms. This is of
course leading to greater dependencies and integration of disciplines across firm
boundaries in an interactive innovation system (Swan et al, 2004). Diverse inputs
from within the network contribute towards creative exploration and the effective
exploitation of ideas, which subsequently improve the outcomes achieved for the
amount of resources invested (Oliver, 2004; Murray, 2004; Powell et al, 1996). One
way to achieve heterogeneity within a network is for organizations to gain preferred
partner status within the sector communities (Dyer et al, 2001). Having a reputation
which attracts a plentiful of partners allows firms to exercise sufficient choice in
selecting collaborators, and achieve higher levels of network involvement and access
to a diverse and rich knowledge base (Powell, 1998 and Florida et al, 2003).
Openness and security
Firms operating in networks may experience a level of insecurity arising from
knowledge sharing activities, which carry potential risks to their IPR. The
mismanagement of such tensions can impose limitations on the amount of learning
that might take place amongst network partners (Owen-Smith & Powell, 2004;
Gargiulo & Benassi, 2000). Whilst the benefits of ‘openness’ and reaching outside
firm boundaries can not be over-emphasized (Burt, 1997; 1992), a degree of caution
and ‘closure’ also needs to be exercised (Coleman, 1990; 1998). Consequently,
networked firms will often devise mechanisms to ensure an appropriate level of
security and closure, particularly if their interactions are due to exploitative activity
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e.g. memorandum of understanding, consortium agreements, legal and non-disclosure
agreements, exclusive licensing contracts, version control or proprietary access etc.
Connectivity
Human connectivity that can be augmented through digital connectivity (internet and
intranet) and its ancillary developments such as e-mail, file transfer protocol, user
generated collaborative cyber workspaces, social networking software, video/web-
conferencing etc, can deliver knowledge advantages (Belussi and Arcangeli, 1998).
Good connectivity or heavyweight membership of a network often results in firms
occupying multiple locations in a wider network. This high involvement strategy can
lead to other intangible benefits such as enhanced professional profile and reputation.
In addition, it may also result in increased adjacency to multiple channels of
knowledge flow, enabling swift navigation through a diverse resource base (Kostova
& Roth, 2003; Prusak & Lesser, 1999). Such high involvement can often be a largely
bridging activity across what Burt (1992) calls ‘structural holes’ in networks, and
needs to be complemented with sufficient bonding level activity to foster communities
of practice (CoP). This process of communalization will embed social structures in
CoPs, often predicated on trust, which becomes an important coordination mechanism
within interorganizational networks.
Learning and knowledge transfer
Networks can benefit from engendering a dual approach to knowledge transfer in
which learning is pursued in a both responsive and proactive manner. Therefore the
sharing of experiences between networked firms through the exchange of dialogue as
a means of knowledge diffusion (Prusak & Cohen, 2001; Powell, 1998) is very much
encouraged. The further construction of systematic measures (for e.g. may include
co-publications and co-patenting) to diffuse the learning within networks is also
strongly advocated (Owen-Smith & Powell, 2003; Murray, 2004; Orsenigo et al,
2001; Powell, 1998 and Powell et al, 1996). In doing so the network is able to
endorse the view of ‘learning as participation’ and a kin to CoPs, as separate from the
view ‘learning as acquisition’ (Yli-Renko, Autio & Sapieza, 2001).
Relationship management
Networked organizations can improve innovation outcomes by increasing relational
strength (Nahapiet & Ghoshal, 1998) by promoting trust and flexibility through low
levels of prescription. This for example means having shared norms, values,
obligations and expectations which facilitate benevolence leading to achieving the
intended outcomes (Adler & Kwon; 2002; Bolino, Turnley & Bloodgood; 2002). In
terms of enhancing flexibility, trusting relationships encourage informal monitoring
and a reduced reliance on formal governance mechanisms with high levels of
prescription (Barney & Hansen, 1994). Networks with high degree of relational
strength can engender a high reliability organization with improved levels of
redundancy for greater flexibility and responsiveness to changing demands (Smart et
al, 2003; Newell, Tansley & Huang, 2004).
Continuous and discontinuous renewal
Networks are not static structures and as connections continually evolve, the resource
pool in the network is renewed through the multiplicity of collaborating arrangements
ongoing (Cross, Borgatti & Parker, 2002). We can deploy the term ‘ambidextrous
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innovation’- the simultaneous pursuit of both incremental and discontinuous change
(O'Reilly III Tushman, 2004; Tushman and O'Reilly III, 1996) to describe the need
for firms in networks to be linked in a multifaceted capacity. For example, firms
involved in networks to explore specific know-how must also be cognizant of the
potential to exploit existing capabilities within the same or different relationship. We
use the term ‘Explo-ti-ring’- exploiting existing capabilities and exploring new
opportunities (Uzzi & Lancaster, 2003) to describe this phenomenon. Simple being
aware of these notions allows networked firms to make more informed and strategic
decisions about how to best apportion their R&D investments.
Complexity and embeddedness
Complexity in the biopharmaceuticals sector often implies escalating advances in
science and technology which demand firms to be part of a wider network to explore,
understand, learn and exploit the underpinning knowledge (Owen-Smith et al, 2002;
Pyka, 2002; Frenken, 2000). Another dimension to complexity is that of structural
complexity, occurring due to the inevitable embeddedness and nesting of different
networks, further complicated by the various path dependencies of firms (Gulati,
Nohria & Zaheer, 2000; Stevenson & Greenberg, 2000). Essentially the key concern
for networked firms is how to navigate from within these structures, the relevant
learning and knowledge which has been generated (Powell, 1998). In such
circumstances considering a firm’s connections as a strategic portfolio of
collaborations, that can be manipulated to identify knowledge and technology
complementarities or synergies within a network, could be beneficial.
Phase 2: Empirical study - expert semi-structured interviews
Table 4 (see Appendix 1) presents a scattergram which summarizes the Theme Based
Content Analysis (TBCA) of the 45 expert interviews, and consisted of transcripts,
detailed notes, corporate documentation and other archival records. It illustrates a
range of emerging themes and related sub-themes, indicative of the macro and micro
level considerations informing management practices linked with interorganizational
innovation.
The theoretical framework of 10 key constructs derived from the SR process was used
as an analytical lens to further investigate the empirical data and conflate the studies.
The resultant synthesis identified 7 theoretically and empirically grounded
technological rules associated with effective interorganizational networking for
innovation. They embody evidence ex post of networking theory and practice. In
doing so, the rules compose vital design-oriented knowledge which provides a
solution architecture of viable action options for managers a priori, to purposefully
design innovation networks. The rules are presented in table 5 and further field-
testing through application is recommended as an important antecedent to future
management action.
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Table 5: Emerging Technological Rules
10 Constructs
Sys. Review
Exemplary empirical evidence
7 Emerging
Rules
Dynamic view  Emphasis on ‘disease centeredness’ and ‘targeted treatments’ results in holistic and long-term networks
 Sophisticated multi-NPD phase collaborations engage a product ‘life-cycle’ perspective e.g. deploying co-development, co-marketing, co-promotion, in-licence, out-
licence, hybrid ‘out-in’ licensing, strategic alliancing, merger and acquisition
 New business models and ‘rules of engagement’ favour more flexible and multi-NPD phase collaborations
 Venture capitalists seek evidence of commercialization networks (for e.g. manufacturing, marketing, and logistics)
Design for
lifecycle
Structure and
process
 New structures for coordinating co-NPD e.g. Office of Alliance Management
 Interorganizational collaborative capability considered as a core organizational competence
 Seeking partners with successful history of co-NPD and collaborative capability is deployed as an explicit network creation strategy
 Strategic management of IP intensified external scouting in specific therapeutic/geographical areas for key scientists, professors and serial entrepreneurs
 Quest for technological synergies and complementarities drives product innovation
Design for
proactive
management
Unintended
consequences
 Senior management recognize benefits resulting from the unintended outcomes of formalised networks
 Creating conditions for creativity and serendipity (e.g. acceptance of ‘under the bench’ research)
 Capitalising on existing social networks in the industrial community and geographical clusters
 Informal and formal networks spin out of existing networks in a self organizing manner
Design for
emergence
Heterogeneity  Splitting and outsourcing of R&D functions forges new links with service and technology providers
 Diverse partners in networks symptomatic of the increased fragmentation of disciplinary knowledge and division of labour e.g. clinical research organizations,
incubators, knowledge brokers, NPD teams, micro-biologists, medicinal chemists, nanotechnologists, proteomics scientists, contract manufacturers, bioinformatics,
gene expressionists/sequencers, statisticians, computer scientists, bioinformatics, structural biology, combinatorial chemistry and high throughput screening
 Emerging ‘Systems Biology’ paradigm encourages greater multidisciplinarity
Design for
diversity
Connectivity
Relationship
Management
 Prolific network participation is a distinctive feature of the biopharma industry (e.g. discovery networks, developments networks, social networks, manufacturing
networks, IP networks, regional networks, dti mission networks, networking networks, professional networks/conference circuits)
 A profile and voice in the community is a valued outcome of participation in various networks
 Search for strategic network partners within existing networks (e.g. access into social/professional networks of serial entrepreneurs, industry veteran’s and key scientists)
 Strategic network partners are recruited to numerous scientific boards of new start-ups
Design for
high
involvement
Learning &
knowledge
transfer
 Adoption of knowledge management systems in interorganizational NPD teams
 Dedicated time to pursue personal research interests through experimentation
 Desire to ensure learning is not divorced from the practice of scientists
 Using formalised industrial networks to explore new scientific and technological discoveries
Design for
diffusion
Embeddedness
& complexity
Openness &
security
Continuous &
discontinuous
renewal
 The embeddedness and overlapping nature of different networks is widely acknowledged
 Portfolio project management techniques are being considered to strategically manage co-NPD collaborations. For e.g. loosely coupled contracts for exploration (with
low barriers to entry) and tightly coupled (high specified agreements) for exploitative (high barriers to entries) activity
 In licensing IP and links with key scientists for tacit knowledge of disease progression and pathology
 Patents expiries on some blockbusters and me-too products within next 5-10 years is encouraging prolific scouting IP for new niche product offerings
 Standardization e.g. electronic note book enables sharing of experience, yet increased insecurity regarding knowledge spill-overs
 Complexity arising from engagement in product, process technology oriented networks
 IP insecurity addressed through links with executive education providers for bioscience professionals
Design for
strategic
innovation
portfolio
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Overall, the research findings confirmed the chief assertions in the extant literature
regarding the state of flux in the pharmaceutical industry, and the promises of the
rapidly growing biopharmaceutical sector. They also confirmed the widespread
aspirations and practice of interorganizational innovation, as a viable strategy for
long-term competitive advantage by creating new value through the combination and
exchange of knowledge resources. This is exemplified with the rising number of
biotech-BigPharma collaborations and the generally well networked bioscience sector.
The evidence of what constitutes effective interorganizational networking practice for
innovation, signalled a disproportionate emphasis in favour of networking processes
as distinct from their counterpart network structures. For example, these included
processes for selecting network partners, limiting knowledge spill-over in
geographical clusters, co-learning, strategic positioning in multiple networks,
recognising the importance of informal social ties in facilitating collaboration and the
effective management of Intellectual Property Rights (IPR).
Managerial implications: technological rules and design-oriented knowledge
Conflating the theoretical and empirical findings has identified a set of 7 grounded
technological rules, associated with effective interorganizational networking for
innovation. More specifically, they comprise vital design-oriented knowledge for
purposefully designing the structures and processes of effective networks. Thus
improving practices associated with operationalizing inter-organizational innovation
networks through improved design, at both the strategic and operations management
levels.
Collectively these rules represent a tentative taxonomy, a means of classifying design
principles, to assist managers in navigating their decision making processes and
devising appropriate network development strategies. It acts as a useful framework
for evaluating current managerial practice and considering the range of possibilities
available to guide future action. In essence, the managerial implications of these rules
suggest that, together they provide an overall architecture for innovation management
solutions at an inter-organizational level. Figure 1 illustrates a conceptualisation of
the relationship between the taxonomy of rules and management action. Further field-
testing of these tentative rules through application is recommended. The following
sections briefly consider the managerial implications of each rule.
Figure 1. Conceptualising the relationship between rules and action
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Design for lifecycle
The design for lifecycle rule conflates the theoretical construct ‘dynamic perspective’
and management practices associated with increasingly varied and sophisticated co-
new product development (co-NPD) strategies. The implication of this rule for
managers is that they need to be mindful of the potential for collaborative
opportunities within the entire product lifecycle during co-NPD strategy formation.
Therefore, they should seek to ensure sufficient flexibility in their negotiations with
potential partners to allow for multi-phased co-NPD involvement where appropriate.
In other words, co-NPD strategies restricted to single phases of the NPD process i.e.
(design or development) hold the risk of limiting the potential to collaborate during
other downstream activities (i.e. marketing and logistics) in a more holistic and
profitable manner. This approach is echoed in the following quotation:
“We went from out-licensing of everything to out-licensing in agreements and asking a bigger
piece of the pie, going through different business models, in turn developing bigger
infrastructure, capabilities and then asking later on not only to co-develop, co-market and
then became bigger ourselves.” (Head of Drug Discovery, Biotech)
Design for proactive management
The design for proactive management rule conflates the theoretical construct
‘structure and process’ and management practices associated with the coordination of
networks. For example, setting up formal structures (i.e. small departments and units)
and the processes to manage external linkages with co-NPD partners is becoming
increasingly common. The implication of this rule for managers is to recognize that
the effective operation of networks demands a degree of proactive management.
More specifically, this needs to be done with the appreciation of a generic process of
network development at play (i.e. creation, operation & closure of external linkages),
if the full benefits of innovation, such as identifying complementarities and synergies
for exploitation purposes are to be reaped. In the words of one of our senior
professionals:
“There is an orchestrated networking program going on.” (Alliance Manager, Biotech)
Design for emergence
The design for emergence rule conflates the theoretical construct ‘unintended
consequences’ and management practices associated with creating the conditions in
which creativity and serendipity are encouraged. Often this invites a recognition of
the self organizing characteristics of networks. The implications of this rule for
managers is to acknowledge the informal channels through which innovation and
learning take place which, by their very nature, do not lend themselves to formal
management controls. Valuing and harnessing this informality will enable greater
scope to capitalize on the ad-hoc and emergent properties of network dynamics. This
viewpoint was expressed by one of the research participants as follows:
“How you find out something is very ad hoc. Something someone says will spark something in
someone else mind. We can only but try to create opportunities for serendipity.” (Head of
Bioinformatics, Big Pharma)
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Design for diversity
The design for diversity rule conflates the theoretical construct ‘heterogeneity’ with
management practices associated with increasing the levels of diversity to enrich the
NPD process. This is partially due to the separation of some research from
development activities, and the generally higher levels of complexity in new products,
compounding the greater fragmentation of core disciplines and specialization. The
implications of this rule for managers is to encourage diversity of NPD experience,
skills, and disciplines in networks to enhance the creative potential for innovation,
decision making and speed to market. The significance of diversity is clearly
witnessed in the following quotation:
Design for high involvement
The design for high involvement rule conflates the notions of ‘connectivity’ and
‘relationship management’ and management practices associated with increasing
levels of involvement of people with different backgrounds in networked NPD.
Essentially;
“[Success] It all boils down to individual relationships. The whole area of relationship
management is very tough. We should never underestimate how important relationship
management is, or the individuals who are required for maintaining this. It falls down to the
two people at the interface – the person in charge of the liaison from the BigPharma side with
the person from the biotech.” (Alliance Manager, Biotech)
The implication for managers is to recognize that productive networks depend on
prolific connectivity at both the structural level, (i.e. to create new ‘bridges’ between
people and organizations) and the processual level (i.e. to ‘bond’ the new relationship
through nurturing). For small bioscience firms these heightened levels of connectivity
allow them to develop both a voice and profile in the community.
Design for diffusion
The design for diffusion rule conflates the construct ‘learning and knowledge transfer’
with management practices associated with knowledge management within networked
NPD teams. In the bioscience community, scientists are keen to ensure learning is not
divorced from practice by confining it to the pursuit of formal qualifications. The
implication for managers is to create practice-based learning opportunities within
networks to facilitate knowledge transfer and not to limit learning to the traditional
realms of the classroom. A key judgment that managers might seek to make is the
degree of integration between the various networks that operate at the individual and
firm level, to gauge the relative ease by which knowledge can flow through them.
This will also assist the identification of further learning opportunities. The following
quotation illustrates the potential for learning through networks:
“It dawned on us that we have to invest in developing phenomenal networking capabilities, to
help us to learn. The stakes were really high, the top management team had to come in
“We want a lot of inter-disciplinarity; a lot of transferable skills. People working in R&D
should speak a diverse language. Since everyone is looking at different levels of details and
different levels of complexity, there are different priorities, different scales, different
magnitudes, and different parameters. It’s is a very complex world.” (Head of Bioinformatics,
Big Pharma)
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agreement and we had to develop this as mission critical to survive.” (Head of Drug
Discovery, Biotech)
Design for strategic innovation portfolio
The design for strategic innovation portfolio rule conflates the constructs
‘embeddedness and complexity’, ‘openness and security’ and ‘continuous &
discontinuous renewal’ and the management practices associated with coordinating
multiple and different networks, some of which are embedded (e.g. one off co-venture
agreements nested within a strategic alliance) and serve different purposes. Whilst
this situation is indicative of greater levels involvement and openness in R&D, it also
breeds insecurities regarding IPR issues:
“There is public and private research. Public research is publications driven. Within
commercial private settings, there is privacy. Scientists are very nervous with their data. They
always hold it close to their chest. If you want to apply for a patent for a chemical compound,
then this data is a trace of your systematic research. For over 15 years there has been a
discussion to let’s make this lab journal electronic, but this has not happened. There is a very
strong reluctance to publish data.” (R&D Manager, Big Pharma)
The implication for managers is to consider their firm’s involvement in networks as a
strategic portfolio of their collaborative efforts. In doing so, they can begin to
distinguish different types of networks (i.e. strategic alliance, learning network, joint
venture etc) and their related purpose (i.e. explorative or exploitative) to better
manage IP issues (e.g. security, risk and knowledge spill over).
Clearly bioscience firms are evolving their interorganizational networking capabilities
in response to the challenges of creating new resources and value as they pursue
product development. The authors consider this response within the context of a meta
understanding of the industry dynamics and, how they might be strategically managed
for achieving future competitive advantage. Therefore, the following section explores
the overriding notion of interorganizational innovation from a Dynamic Capabilities
View, an increasingly popular theoretical perspective in the field of Strategic
Management. In doing so, we seek to complement the implications for managerial
practice, as discussed in an earlier section, with a consideration of the implications for
strategic management theory.
Discussion: Exploring a Dynamic Capability View
Network Development Capability
The last decade has witnessed an upsurge in research seeking to incorporate different
strategic management perspectives in the field of operations management and strategy
(Gagnon, 1999; Pandza et, al, 2003; Mills et al, 2003; Miller and Ross, 2003). In
particular, this work has begun to demonstrate the relevance of the Resource-Based
View (RBV) and Dynamic Capability Views (DCV) to improved future research and
practice. More recently, Pilkington and Fitzgerald (2006) foresee this shift to become
a prominent perspective focussing away from a Porterian paradigm, and more towards
a consideration of internal capability development for sustainable competitive
advantage. They go on to suggest that studies conducted under this up-and-coming
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wave are ‘seeking a more subtle understanding of operations management by
considering its practice in relations to strategy, context and resources’. Thus making it
a useful theoretical departure point for our research. We hope to advance this
emerging discourse by advocating new capabilities to coordinate network
development relevant to strategy and operations in competitive global landscapes. In
trying to do so, we stress the important role of strategic alignment and some
‘synergistic process of integrating business and operations strategic issues’ (Anderson
et al, 1989) for significant impact on organization performance.
The research findings indicate that the industry dynamics in the burgeoning
biopharmaceuticals sector are shifting the locus of knowledge and value creation
within the supply chains. The locus is moving away from the firm to being spread
over a wider network of heterogeneous firms. This change is becoming a dominant
design feature of the industry and signals an urgent need to develop
interorganizational networking capability for the purposes of innovation. In this
section the authors consider the DCV as a useful theoretical view, derived from the
RBV of the firm, to explore an explanation for this relocation of knowledge and value
creation (Barney, 1991, Nelson, 1991; Penrose, 1959; Prahalad and Hamel, 1990;
Teece et al, 1997). In doing so, the authors highlight the significance of a dynamic
capability which addresses the renewal of a network-specific resource base.
The RBV explores the link between internal features of the firm and its performance
(Barney, 1991). At the heart of the theory lies the argument that organizations are a
bundle of resources, that are simultaneously Valuable, Rare, Imitable and Non-
substitutional, or in other words ‘pass’ Barney’s VRIN test. Essentially the RBV
locates the source of competitive advantage inside the firm and associates rent
generation with VRIN qualified resources, controlled by the firm. To briefly
summarize, the RBV discusses value creation through alterations in the firm’s
heterogeneous resource base that is considered to be idiosyncratic and sticky in
relation to the firm itself, or in other words ‘firm-specific’. Finally, the RBV deals
with the business level question of how to compete and is espoused to be a static
theoretical perspective, as it considers resources at a specific point in a firm’s history
(Preim and Butler, 2001).
A relatively recent elaboration of the RBV of the firm, the DCV, addresses the
underpinning organizational routines associated with future resource creation. The
DCV focuses on the capacity of a firm to renew resource bundles or in other words
‘integrate, build and reconfigure internal and external competencies to address
changing environments’ (Teece et al 1997). Whilst the functionality of such
dynamics capabilities is generic, their value lies in the resource configurations they
create and not in the capabilities themselves (Eisenhardt and Martin, 2000). In a
manner not dissimilar to Henderson and Cockburn (1994) conception of ‘architectural
competence’, this signals a co-evolutionary process in which the interaction of
resources, competencies and capabilities within the firm are transformed into
competitive advantage.
Major theoretical contributions to both the RB and DC views do not fully develop
their discourse at the interorganizational level. Therefore, Cohen and Levinthal’s
(1989) depiction of the crucial role of knowledge creation through endogenous R&D
efforts and discussion of ‘absorptive capacity’, combined with the adoption of
Towards Technological Rules for Designing Innovation Networks: a Dynamic Capabilities View
18
technologies developed by others (outside the firm) for successful innovation, present
a significant challenge to the traditional RB and DC view. However, the authors
argue there is scope for the RB and DC views to better inform the broader practice of
managing innovation in an increasingly multi-player (or network) context.
Hagedoorn and Duysters (2002) more recently fortify the DCV by similarly stressing
the importance of the efficient use of external resources. Similar sentiments are borne
in the light of more recent discussions by Day & Shoemaker (2006) of how
companies develop ‘peripheral vision’ - a propensity to exercise vigilance over the
demands of their environments and so maintain a competitive position. The various
contributions of these authors are alluding to the importance of knowledge and value
creation being located outside the boundary of the single firm.
Inspired by the DCV the authors propose that, in the context of fast changing
biopharmaceuticals environment, the notion of the ‘firm’ is a distinction that needs to
be relaxed and elevated to an ‘inter-firm’ conceptualisation. Following on from this
proposition, the authors suggest that the various connections or relationships between
firms in a wider inter-firm network can in themselves amount to being ‘network
resources’ and specific to the network itself. Whilst such resources exist in the spaces
between individual firms they still pass the VRIN test, yet are not controlled by any
single firm and so present a different category of resource altogether, to that which is
articulated by the traditional RBV. In this new category, the control of resources is
considered to be distributed within the network. A further distinction from the
traditional RBV is that for these resources for many biopharmaceutical firms come
with the promise of future rents, rather than actual rents. As Bowman and Ambrosini
(2003) indicate ‘because the processes of resources creation are not well understood,
and because the identification of rent generating resources is problematic, we have to
examine the processes of asset creation’. Due to causal ambiguity it is difficult to
determine which particular activities if enacted will result in the creation of ‘true’
resources that fulfil the VRIN tests. Bowman and Ambrosini (2003) go on to suggest
that it might be appropriate to investigate the activities and processes that should
create assets (non rent generating resources) and may result in new resources (i.e.
those that are rent generating).
Therefore in the biopharmaceuticals sector, dynamic capabilities associated with the
resource creation (both assets and resources) cannot be simply considered to be ‘firm
specific’, as some are likely to be enacted at higher level, within a wider network at an
inter-firm level. Subsequently these capabilities reconfigure assets and resources that
are both specific to the firm and specific to the wider network, through an inter play
which may allow for certain resources to become more idiosyncratic and perhaps
firm-specific over-time. Therefore, the wider network contributes to knowledge and
value creation by exhibiting dynamic capabilities. Whether or not the process of new
resource creation is triggered reactively or proactively, it may involve processes of
coordination, replication, learning and reconfiguration (Teece et al, 1997). In alluding
to Bower’s (1993) network approach we recognise the possibility of firms accessing
resources not simply through direct relationships, but also via third party relationships
and contributors to the total resources of the wider network.
With a view to developing the theoretical discourses in the DCV at an inter-firm and
network level, the authors highlight the significance of a dynamic capability which
addresses the renewal of network connections and relationships (i.e. a resource and
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asset base that is specific to the network) in line with changes to its environment. It is
essentially concerned with the network development process (i.e. creation, operation
and closure). If we consider Makadok’s (2001) argument that dynamic capabilities
are built rather than bought in the market, and so embedded in the firm, this dynamic
capability is similarly nurtured over time, yet embedded in a wider network. Indeed
network connections and relationships are considered to be network-specific assets
and resources, that would display path dependencies and so difficult to imitate. The
theoretical implications of such a suggestion are that we relax our distinctions of what
constitutes the firm and consider the network as a higher order entity that may also
possess assets and resources, and so suggest a blurring between firm and network
level strategic issues. This reflection inevitably calls into question the idea of ‘firm-
specificity’ in the traditional RB and DC views. The challenging role for the
networked firm is the creation of new resource configurations from within a resource
base that is controlled in a distributed manner by networked firms. Our propositions
amount to dynamic capability that is not simply performed by the single firm, but is
enacted and performed at the network level. Our suggestions to some extent
corroborate Dyer and Singh (1998) notion of relational capability development.
It seems reasonable to advocate that competitive advantage cannot be manipulated
within the boundary of the single firm as assumed by a traditional RB and DC views
with their preoccupation with firm-specific resources and capabilities, enacted at the
firm level. In the growing biopharmaceuticals industry the locus for innovation is
shifting into a broader network of firms, rendering a preoccupation with leveraging
network-specific resources and capabilities as worthwhile. Firms recognising they are
a ‘node’ in a network can encourage competitive advantage through the careful
renewal of network connections and relationships. Indeed new assemblies and bundles
of such network resources could potentially generate the new and unique value.
Conclusions and Further Research
Relatively novel organizational forms such as networks are being deployed to access
new technologies and their associated know-how to improve innovation capacity.
Such opportunities to exploit superior external knowledge resources for new product
development have become a distinctive feature of the burgeoning biopharmaceuticals
industry. Consequently, the prevailing industry dynamics are shifting the locus of
knowledge and value creation away from the firm and into the broader enterprise of
the network. This poses important questions concerning the nature of resources that
reside in the space between firms and how they are leveraged for innovation. Such
inquiries are relevant to improving practices associated with operationalizing inter-
organizational innovation networks, at both the strategic and operations management
levels.
This research has deployed van Aken’s seminal ideas about generating design-
oriented knowledge to assist managers in pursuit of the benefits of inter-organization
innovation. It reveals 7 empirically and theoretically grounded technological rules
associated with the effective inter-organizational networking for innovation, through
improved design. They compose vital knowledge which provides solution architecture
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of viable action options for managers a priori, to purposefully design innovation
networks. Collectively the rules represent tentative taxonomy, a means of classifying
design principles for managers to shape their decision making processes and devise
appropriate network development strategies and operations. It also acts as a useful
framework for evaluating current managerial practices and considering the range of
possibilities available to guide future action. Thus constituting valuable transferable
knowledge to support improvements in organizational innovation capacity and
performance.
In acknowledging that this research contributes a tentative taxonomy of design rules
for practicing managers, we recommend field-testing as an important antecedent to
management action. A further limitation of this research is its focus on
Biopharmaceuticals sector, and so future investigations to refine the taxonomy should
span additional industrial contexts.
Finally, following the recent upsurge in research incorporating different strategic
management perspectives in the field of operations management and strategy, we
succumb in the same spirit. In seeking to advance this emerging discourse we
consider the resource-based and dynamic capability views, and advocate new
capabilities to coordinate network development. More specifically, we highlight the
significance of a dynamic capability which addresses the renewal of network-specific
resources in response to changes in the competitive environment. Unlike dynamic
capabilities enacted at the firm level, this one is enacted at a network level.
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Appendix 1
Table 4: Scatter plot of Emerging Themes
